Trade Ideas April 10, 2026 05:48 AM

SSR Mining: Buy the Deleveraging Trade After $1.5B Copler Sale and Insider Accumulation Reports

A conservative long with a clear stop—buy into balance-sheet repair and buyback optionality as the company refocuses on the Americas

By Marcus Reed SSRM
SSR Mining: Buy the Deleveraging Trade After $1.5B Copler Sale and Insider Accumulation Reports
SSRM

SSR Mining (SSRM) just agreed to sell an 80% stake in its Çöpler (Turkey) mine for $1.5 billion and announced a share-repurchase program. The deal meaningfully de-risks the portfolio and funds buybacks/reinvestment. With a market cap near $6.8 billion, low leverage and decent FCF, this is a trade to buy on execution and momentum — provided regulatory approval proceeds and buybacks materialize.

Key Points

  • SSR Mining agreed to sell an 80% stake in the Çöpler (Turkey) mine for $1.5 billion, providing a material cash infusion.
  • Company has low leverage (debt/equity ~0.11), positive free cash flow (~$241.6M), and market cap around $6.8B.
  • Authorized share repurchase (up to 10%) creates buyback optionality; reports cite an initial ~$300M repurchase target in commentary.
  • Valuation is reasonable (P/E ~17-18, EV/EBITDA ~10x); the sale de-risks the balance sheet and could trigger multiple expansion if deployed well.

Hook & thesis

SSR Mining has just handed the market a neat narrative: a $1.5 billion cash sale of an 80% stake in its Turkish Copler asset, plus a newly authorized share-repurchase program. That combination immediately strengthens liquidity and creates optionality—management can pay down liabilities, accelerate projects in the Americas, or return capital to shareholders. For traders who want exposure to gold/silver producers but prefer cleaner balance sheets, SSRM now looks attractive.

The trade thesis is straightforward: buy SSRM on continued pullback or consolidation as the market digests the sale and the buyback program is implemented. The company trades at roughly $6.8 billion market cap, has low leverage (debt-to-equity ~0.11), produces positive free cash flow (reported FCF ~$241.6 million), and still sits well below the kinds of multiples that would reflect a de-risked, cash-rich producer. That combination supports a tactical long with a defined stop loss.

What SSR Mining does and why the market should care

SSR Mining is a multi-jurisdictional precious-metals producer operating assets in the USA, Canada, Argentina and Turkiye. The company produces gold plus copper, silver, lead and zinc concentrates and runs several operating segments including Copler, Marigold, Cripple Creek and Victor, Seabee and Puna. The recent strategic move to sell an 80% stake in the Çöpler mine in Turkey is meant to refocus SSRM on its Americas portfolio and reduce exposure to geopolitical and permitting complexity.

Why this matters: the $1.5 billion proceeds materially strengthen liquidity and give management choices. The company already reports free cash flow of $241,649,000 and a low debt-to-equity ratio of 0.11, so the sale shifts the balance sheet from 'sound' to 'robust' and creates headroom for buybacks, M&A, or capital investments that can drive longer-term production growth.

Hard numbers that support the setup

  • Market cap: roughly $6.8 billion.
  • Enterprise value: approx. $6.68 billion; EV/EBITDA ~10x.
  • P/E: ~17-18x based on EPS ~$1.93 and recent price area; price-to-book ~1.95.
  • Free cash flow: ~$241.6 million, indicating conversion of profits into cash.
  • Balance-sheet strength: debt-to-equity ~0.11 and current ratio ~2.08.
  • 52-week range: $9.88 - $36.52, illustrating a major run higher over the past year and scope for mean reversion if metals soften.

Valuation framing

SSR Mining sits at roughly $6.8 billion market cap today. On an absolute basis P/E in the high teens and EV/EBITDA near 10x are not stretched for a mid-cap gold producer, especially one with multi-commodity exposure and growth optionality. The company also trades at ~1.95x book, which suggests the market is valuing both assets and future cash generation but leaving a premium to be earned if the company executes capital returns or improves production.

Put simply: the $1.5 billion cash infusion de-risks the story and reduces the probability of balance-sheet-driven downside, which should compress required returns and support multiple expansion. If management deploys proceeds into accretive projects or executes on a credible buyback, the market can justify a higher multiple. Conversely, if proceeds are used sub-optimally or regulatory hurdles delay the sale, valuations can re-rate lower.

Catalysts (near- to mid-term)

  • Regulatory approvals and closing of the Copler sale - expected to close in Q3/2026 pending approvals (this is the key execution event that unlocks the $1.5 billion cash).
  • Execution of the share buyback program (management authorized repurchase up to 10% of outstanding shares; initial commentary points to a ~$300 million repurchase target in some reports).
  • Quarterly results and guidance updates that show how management plans to deploy proceeds (project capex vs buyback vs debt repayment).
  • Metal-price direction: gold moves will remain a significant catalyst for sentiment and P&L sensitivity; silver (~24% of revenue in some analyses) will also materially affect near-term results.

Trade plan (actionable)

Direction: Long SSRM

Entry price: $33.42

Stop loss: $30.00

Target price: $42.00

Horizon: long term (180 trading days). Expect this trade to play out over multiple quarters as the Copler transaction clears regulatory hurdles and buybacks or capital redeployment begin to show up in results. The objective is to capture balance-sheet repair, modest multiple expansion, and buyback-driven EPS uplift. If the stock breaks above $42 on volume and positive headlines, reassess for potential upside to $50 depending on metal prices and buyback cadence.

Rationale for levels: entry near current price avoids chasing the rally, stop at $30 preserves capital and respects the stock's recent volatility and short-covering dynamics, target at $42 reflects conservative multiple expansion (to nearer 20x earnings or improved FCF conversion plus buyback impact) while still leaving upside if metals move higher.

Technical and market structure notes

Momentum indicators are currently bullish: the 10-day SMA is near $30.27, 20- and 50-day SMAs near $28.24 and $28.19 respectively, and the 9-day EMA is $31.36. RSI sits around 62, and MACD shows bullish momentum. Short interest recently hovered around ~9.9-12.5 million shares across recent settlements, with days-to-cover typically 2-4 days—enough short interest to amplify moves on positive headlines, but not so concentrated as to imply an imminent squeeze.

Risks and counterarguments

  • Regulatory and timing risk: the $1.5 billion transaction for Çöpler requires regulatory approval in Turkey and other closing conditions; if approvals are delayed or conditions change, the cash won't be available on the timeline the market expects.
  • Asset-value trade-off: selling 80% of Copler reduces future production and reserve exposure. While proceeds improve the balance sheet today, the company also gives up future cash flows from the asset; the market may re-price long-term growth potential lower if the Copler stake was a material source of future production.
  • Commodity-price risk: SSRM's revenue mix includes gold and silver (with silver noted at ~24% of revenue in some industry write-ups). A sustained drop in precious-metal prices would compress margins and reduce the effectiveness of buybacks and capex deployment in lifting EPS.
  • Buyback and capital allocation execution: an authorized buyback is not the same as an executed buyback. Management may choose to deploy proceeds to projects or M&A, or buybacks may be paced slowly; disappointing deployment will disappoint investors expecting immediate EPS uplift.
  • Operational and country risk: SSRM operates across multiple jurisdictions. Permitting, cost inflation, or localized operational setbacks can offset the balance-sheet improvements from the sale.

Counterargument: One valid counter to this long is that the market has already priced much of the positive news into SSRM. The stock recently traded near a new 52-week high ($36.52 on 04/09/2026), and some coverage suggests a >150% run over the prior 12 months. If that sentiment is fueled by momentum rather than fundamentals, a pullback could be sharp if gold or silver weaken or if the sale/buyback news disappoints on execution.

What would change my mind

I would downgrade the bullish stance if one of the following occurs: (a) the Copler transaction is delayed significantly past Q3/2026 or materially renegotiated; (b) management signals it will deploy the $1.5 billion into an expensive, shareholder-dilutive M&A rather than buybacks or accretive project funding; (c) metal prices enter a sustained downtrend that lowers forward margins and FCF expectations; or (d) quarterly results show structural cost inflation or throughput declines at core Americas operations.

Conclusion

SSR Mining's announced $1.5 billion cash sale and a fresh buyback authorization give investors a concrete reason to reassess the stock. The company enters this next phase with low leverage, solid FCF generation (~$241.6 million) and the flexibility to return capital or accelerate growth. For traders comfortable holding through regulatory close risk and commodity swings, a long entry at $33.42 with a $30 stop and a $42 target over a 180-trading-day window is a pragmatic, risk-defined way to play balance-sheet repair plus buyback optionality.

Metric Value
Market cap $6.8B
EV $6.68B
Free cash flow $241.6M
Debt-to-equity 0.11
P/E ~17-18x

Trade idea: Long SSRM at $33.42, stop $30.00, target $42.00, horizon long term (180 trading days). Monitor Copler sale progress, buyback execution, and metal prices closely.

Risks

  • Regulatory approval and closing risk for the Çöpler sale - delays or renegotiation would keep the $1.5B off the balance sheet.
  • Selling 80% of Copler reduces future production and reserve exposure, which could lower long-term earnings power.
  • Commodity-price volatility (gold and silver) could compress margins and negate the benefits of balance-sheet repair.
  • Authorized buybacks may not be executed aggressively; slow or non-existent repurchases would limit EPS upside from the cash infusion.

More from Trade Ideas

Foundayo, Pricing Pressure and the Distribution Wildcard: A Trade Plan on Eli Lilly (LLY) Apr 11, 2026 Teladoc (TDOC): Cheap, Cash-Flowing, and Set for a Mid-Term Stabilizing Rebound Apr 11, 2026 Tesla: Upgrade to Buy — Backing the Robotaxi Re-Entry After the Pullback Apr 11, 2026 Buy WES for Income and Midterm Upside: 9% Yield with Coverage and Capital Discipline Apr 11, 2026 VISN: Clean Balance Sheet and Earnings Momentum Support a Tactical Long Apr 11, 2026